Compounds targeting OGT have minimal effects on the proliferation rate of prostate cancer cells but have profound effects on the mitochondrial activity of these cells (Itkonen et al. 2016; Itkonen et al. 2020). This evidence concerns the gene OGT and Familial prostate cancer.